Clinical Trial Update: SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 trial in Sweden (SWE-NEO) evaluating monotherapy versus combination immunotherapy for resectable Stage III melanoma; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Hildur Helgadottir | Conditions: Malignant Melanoma Stage III | Phase 3 | Status: RECRUITING